Deciphera Pharmaceuticals (DCPH) Misses Q3 EPS by 9c

November 2, 2021 4:33 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($1.37), $0.09 worse than the analyst estimate of ($1.28). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $23.36 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities